Literature DB >> 1862099

Rapid medium perfusion rate significantly increases the productivity and longevity of human bone marrow cultures.

R M Schwartz1, B O Palsson, S G Emerson.   

Abstract

Long-term in vitro human hematopoietic (Dexter) cultures are limited both in their longevity (8-12 weeks) and in their cell production over time. Hematopoiesis in vivo continues unabated throughout life, suggesting that failure to obtain continuous hematopoiesis in vitro is probably due to the failure of culture conditions to accurately reproduce the in vivo state. Since bone marrow cells in vivo exist at high density and are rapidly perfused by plasma components, we examined the effects of the culture medium perfusion rate and inoculum density on longevity and productivity of human bone marrow cultures. Culture efficiency and longevity were relatively independent of the variation in inoculum density from 10(6) to 5 x 10(6) cells per ml but were significantly altered by the medium perfusion rate. Increased culture perfusion was superior to traditional Dexter schedules, with 0.5 medium volume exchange per day (3.5 volume per week) being optimal. The cultures under these conditions demonstrated an increasing rate of cell production from weeks 4 to 10, with the cell production rate doubling approximately every 2 weeks. Following weeks 10-12 in culture, the cell production rate of all cultures decayed. Production of nonadherent progenitor cells was also highest in cultures perfused at 3.5 medium volume exchanges per week, where progenitor cell production was stable from weeks 6 to 18. The nonadherent cells collected were predominantly macrophages by week 19, except for the cultures perfused at a rate of 3.5 volumes per week and seeded at 5 x 10(6) cells per ml, in which production of granulocytes remained high through week 19. Establishment of more optimal perfusion conditions supports the continuous stable generation of progenitor cells over 5 months in culture, suggesting that primitive stem cells are surviving and proliferating in these cultures.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1862099      PMCID: PMC52168          DOI: 10.1073/pnas.88.15.6760

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Kinetics of myeloid progenitor cells in human micro long-term bone marrow cultures.

Authors:  H G Mergenthaler; P Brühl; P Dörmer
Journal:  Exp Hematol       Date:  1988-02       Impact factor: 3.084

2.  Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro.

Authors:  H J Sutherland; C J Eaves; A C Eaves; W Dragowska; P M Lansdorp
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

3.  Stimulation of differentiation and proliferation of haemopoietic cells in vitro.

Authors:  T M Dexter; T D Allen; L G Lajtha; R Schofield; B I Lord
Journal:  J Cell Physiol       Date:  1973-12       Impact factor: 6.384

4.  Assessment of bone marrow blood flow using positron emission tomography: no relationship with bone marrow cellularity.

Authors:  P Martiat; A Ferrant; M Cogneau; A Bol; C Michel; J Rodhain; J L Michaux; G Sokal
Journal:  Br J Haematol       Date:  1987-07       Impact factor: 6.998

5.  Survival of granulocytic progenitors in the nonadherent and adherent compartments of human long-term marrow cultures.

Authors:  F T Slovick; C N Abboud; J K Brennan; M A Lichtman
Journal:  Exp Hematol       Date:  1984-06       Impact factor: 3.084

6.  Human recombinant granulocyte-macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities.

Authors:  S G Emerson; Y C Yang; S C Clark; M W Long
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

7.  Effects of recombinant human granulocyte colony-stimulating factor (CSF), human granulocyte macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in human long-term bone marrow culture.

Authors:  L H Coutinho; A Will; J Radford; R Schiró; N G Testa; T M Dexter
Journal:  Blood       Date:  1990-06-01       Impact factor: 22.113

8.  Culture perfusion schedules influence the metabolic activity and granulocyte-macrophage colony-stimulating factor production rates of human bone marrow stromal cells.

Authors:  J Caldwell; B O Palsson; B Locey; S G Emerson
Journal:  J Cell Physiol       Date:  1991-05       Impact factor: 6.384

9.  Human hematopoietic precursors in long-term culture: single CD34+ cells that lack detectable T cell, B cell, and myeloid cell antigens produce multiple colony-forming cells when cultured with marrow stromal cells.

Authors:  R G Andrews; J W Singer; I D Bernstein
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

10.  Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma.

Authors:  C Verfaillie; K Blakolmer; P McGlave
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

View more
  10 in total

1.  Combination of recombinant cytokines fails to produce ex vivo expansion of human blood hematopoietic progenitor cells.

Authors:  Y Takaue; T Abe; Y Kawano; A Hirao; A Yokobayashi; Y Okamoto; S Saito; T Shimizu; J Sato; T Watanabe
Journal:  Ann Hematol       Date:  1992-05       Impact factor: 3.673

2.  The influence of extra-cellular matrix and stroma remodeling on the productivity of long-term human bone marrow cultures.

Authors:  R M Schwartz; J Caldwell; M F Clarke; S G Emerson; B O Palsson
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

3.  Angiogenic and osteogenic potential of bone repair cells for craniofacial regeneration.

Authors:  Darnell Kaigler; Giorgio Pagni; Chan-Ho Park; Susan A Tarle; Ronnda L Bartel; William V Giannobile
Journal:  Tissue Eng Part A       Date:  2010-09       Impact factor: 3.845

4.  Stem cell therapy for craniofacial bone regeneration: a randomized, controlled feasibility trial.

Authors:  Darnell Kaigler; Giorgio Pagni; Chan Ho Park; Thomas M Braun; Lindsay A Holman; Erica Yi; Susan A Tarle; Ronnda L Bartel; William V Giannobile
Journal:  Cell Transplant       Date:  2013       Impact factor: 4.064

5.  Development of a fixed bed bioreactor for the expansion of human hematopoietic progenitor cells.

Authors:  P Meissner; B Schröder; C Herfurth; M Biselli
Journal:  Cytotechnology       Date:  1999-07       Impact factor: 2.058

6.  Bone marrow-on-a-chip replicates hematopoietic niche physiology in vitro.

Authors:  Yu-suke Torisawa; Catherine S Spina; Tadanori Mammoto; Akiko Mammoto; James C Weaver; Tracy Tat; James J Collins; Donald E Ingber
Journal:  Nat Methods       Date:  2014-05-04       Impact factor: 28.547

7.  Optimized cell survival and seeding efficiency for craniofacial tissue engineering using clinical stem cell therapy.

Authors:  Archana Rajan; Emily Eubanks; Sean Edwards; Sharon Aronovich; Suncica Travan; Ivan Rudek; Feng Wang; Alejandro Lanis; Darnell Kaigler
Journal:  Stem Cells Transl Med       Date:  2014-11-05       Impact factor: 6.940

8.  Ex vivo expansion of primitive hematopoietic cells for cellular therapies: An overview.

Authors:  T A McAdams; C E Sandstrom; W M Miller; J G Bender; E T Papoutsakis
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

Review 9.  Development of 3D in vitro technology for medical applications.

Authors:  Keng-Liang Ou; Hossein Hosseinkhani
Journal:  Int J Mol Sci       Date:  2014-10-08       Impact factor: 5.923

10.  3D models of the hematopoietic stem cell niche under steady-state and active conditions.

Authors:  Lisa Rödling; Ivo Schwedhelm; Saskia Kraus; Karen Bieback; Jan Hansmann; Cornelia Lee-Thedieck
Journal:  Sci Rep       Date:  2017-07-04       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.